Morgan Stanley’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688K | Sell |
|
|||||
|
2025
Q1 | $3.44M | Buy |
|
|||||
|
2024
Q4 | $2.13M | Sell |
|
|||||
|
2024
Q3 | $4.82M | Sell |
|
|||||
|
2024
Q2 | $5.03M | Sell |
|
|||||
|
2024
Q1 | $9.98M | Sell |
|
|||||
|
2023
Q4 | $10.7M | Buy |
|
|||||
|
2023
Q3 | $4.38M | Buy |
|
|||||
|
2023
Q2 | $6.62M | Buy |
|
|||||
|
2023
Q1 | $4.85M | Buy |
|
|||||
|
2022
Q4 | $5.35M | Buy |
|
|||||
|
2022
Q3 | $6.65M | Sell |
|
|||||
|
2022
Q2 | $13M | Sell |
|
|||||
|
2022
Q1 | $15.4M | Buy |
|
|||||
|
2021
Q4 | $18.9M | Buy |
|
|||||
|
2021
Q3 | $27.3M | Sell |
|
|||||
|
2021
Q2 | $29.5M | Buy |
|
|||||
|
2021
Q1 | $3.3M | Sell |
|
|||||
|
2020
Q4 | $8.65M | Buy |
|
|||||
|
2020
Q3 | $7.56M | Buy |
|
|||||
|
2020
Q2 | $2.02M | Sell |
|
|||||
|
2020
Q1 | $920K | Sell |
|
|||||
|
2019
Q4 | $2.08M | Buy |
|
|||||
|
2019
Q3 | $864K | Buy |
|
|||||
|
2019
Q2 | $260K | Buy |
|
|||||
|
2019
Q1 | $260K | Sell |
|
|||||
|
2018
Q4 | $990K | Buy |
|